Roche's innovative sequencing by expansion (SBX) technology represents a leap forward in next-generation sequencing (NGS), which is playing a vital role in decoding complex diseases like cancer, ...
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run for its money. Illumina has long ...
The newest DNA sequencing technology from Swiss multinational Roche doesn’t measure DNA directly but in fact analyzes a different polymer altogether. The technology is not yet available for sale, but ...
Roche raised the curtain on its novel approach to DNA sequencing earlier this year, and now it's working with the Broad Institute to explore its use cases, ahead of a full public launch slated for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results